The gastrointestinal disorder drug developer was co-founded by researchers from Stanford University.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Osage University Partners has helped the UT Southwestern precision medicine spinout close a round which will be used to advance and expand its pipeline of respiratory disease drug candidates.